All comparisons
LLY vs NVO
Eli Lilly and Company vs Novo Nordisk A/S
Overview
LLYEli Lilly and Company
Score A+Price
$1,175.15
Fair Value
$1,405.38
Upside
+19.6%
Convex Score
10/10
NVONovo Nordisk A/S
Score BPrice
$49.38
Fair Value
$78.21
Upside
+58.4%
Convex Score
10/10
Valuation
LLY
Bear$1,057.64
Base$1,637.77
Bull$2,844.39
Fair Value$1,405.38
NVO
Bear$44.44
Base$69.56
Bull$76.52
Fair Value$78.21
Quality
LLY
Grade
A
Score
116/100
Classification
Growth
Rating
Score A+
NVO
Grade
A
Score
106/100
Classification
Compounder
Rating
Score B
Company Info
| LLY | NVO | |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - General | Drug Manufacturers - General |
| Classification | Growth | Compounder |
Verdict
LLY has better risk/reward
NVO: Higher upside potentialLLY: Better quality grade